Dr. Naftali Kaminski

Naftali Kaminski, MD, is a physician-scientist specializing in pulmonary and critical care medicine, with subspecialty expertise in interstitial and fibrotic lung disease. He is the Boehringer-Ingelheim Endowed Professor of Internal Medicine at Yale School of Medicine, director of the Center for Pulmonary Injury, Repair and Therapeutics, co-director of the Clinical Investigation Concentration in the Master of Health Science Program, and an attending physician with Yale Medicine and Yale New Haven Health. His clinical focus includes interstitial and fibrotic lung disorders, complex airway and inflammatory lung conditions, and pulmonary injury and repair. Dr. Kaminski’s research interests center on the molecular and cellular mechanisms of lung injury, repair, and fibrosis; genomic, transcriptomic, and single-cell approaches to human lung biology; and biomarker-driven and AI-enabled translational research in respiratory medicine. A recognized leader in the field, he previously served as section chief of Pulmonary, Critical Care and Sleep Medicine at Yale and has also held major academic and research leadership roles at the University of Pittsburgh and Sheba Medical Center. His honors include the Morgagni Award for Scientific Research, the J. Burns Amberson Honorary Award Lecture, the ERS Gold Medal for Interstitial Lung Disease, and election to the Connecticut Academy of Science and Engineering and the Association of American Physicians. He earned his medical degree from Hebrew University-Hadassah Medical School in Jerusalem, completed his residency in internal medicine at Hadassah University Hospital, and pursued fellowship training in pulmonary medicine at Sheba Medical Center, Tel-Hashomer. He also completed advanced research training at the Lung Biology Center at the University of California, San Francisco, and in functional genomics at Roche Bioscience.